106.818 articles found

Sort:

Source record

Computerised brain electrical activity findings of parkinson patients suffering from hyperkinetic side effects (hypersensitive dopamine syndrome) and a review of possible sources.

Fünfgeld EW.

J Neural Transm Suppl · 1995-01-01

PMID: 8821071

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Fluctuations in Parkinson's disease. Pathogenetic significance of levodopa's cerebral pharmacokinetics and pharmacodynamics.

Baas H, Harder S, Demisch L, Bürklin F, Stecker K, Fischer PA.

J Neural Transm Suppl · 1995-01-01

PMID: 8821072

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.

Fischer PA.

J Neural Transm Suppl · 1995-01-01

PMID: 8821073

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

DATATOP-study: significance of its results in the treatment of Parkinson's disease.

Schneider E.

J Neural Transm Suppl · 1995-01-01

PMID: 8821074

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Twenty-five years of amantadine therapy in Parkinson's disease.

Danielczyk W.

J Neural Transm Suppl · 1995-01-01

PMID: 8821075

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Intravenous application of amantadine and antiparkinsonian efficacy in Parkinsonian patients.

Müller T, Kuhn W, Quack G, Przuntek H.

J Neural Transm Suppl · 1995-01-01

PMID: 8821076

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Amantadine in Parkinson's disease: pro and contra.

Greulich W, Fenger E.

J Neural Transm Suppl · 1995-01-01

PMID: 8821077

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dopaminergic effects on cognitive performance in patients with Parkinson's disease.

Lange KW, Paul GM, Naumann M, Gsell W.

J Neural Transm Suppl · 1995-01-01

PMID: 8821078

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Subjective time estimation in Parkinson's disease.

Lange KW, Tucha O, Steup A, Gsell W, Naumann M.

J Neural Transm Suppl · 1995-01-01

PMID: 8821079

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The current significance of physiotherapeutic measures in the treatment of Parkinson's disease.

Ulm G.

J Neural Transm Suppl · 1995-01-01

PMID: 8821081

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Old and new dopamine agonists in Parkinson's disease. Proceedings of an international congress. Pisa, Italy, December 1993.

Check source for author details

J Neural Transm Suppl · 1995-01-01

PMID: 8847537

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Experimental models and behavioural tests used in the study of Parkinson's disease.

Mokrý J.

Physiol Res · 1995-01-01

PMID: 8869270

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.